Recent Quotes (30 days)

You have no recent quotes
chg | %

Roche Holding Ltd. (ADR)  

(Public, OTCMKTS:RHHBY)   Watch this stock  
Find more results forPINK:RHHBY
32.70
-0.04 (-0.12%)
Apr 28 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 32.54 - 36.82
52 week 25.25 - 36.82
Open 32.62
Vol / Avg. 390,065.00/1.07M
Mkt cap 229,780.77M
P/E 23.35
Div/yield 1.02/3.11
EPS 1.40
Shares 691.93M
Beta 0.83
Inst. own 15%
Mar 14, 2017
Roche Holding AG Annual Shareholders Meeting
Feb 1, 2017
Full Year 2016 Roche Holding AG Earnings Release
Feb 1, 2017
Full Year 2016 Roche Holding AG Earnings Call
  

Key stats and ratios

Q4 (Dec '16) 2016
Net profit margin 16.69% 19.24%
Operating margin 23.18% 27.80%
EBITD margin - 41.26%
Return on average assets 11.24% 12.76%
Return on average equity 39.52% 42.66%
Employees 94,052 -
CDP Score - A

Address

Grenzacherstrasse 124
BASEL, 4058
Switzerland
+41-9-732354295 (Phone)

Website links

External links

Description

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

Officers and directors

Severin Schwan Chairman of the Corporate Executive Committee, Chief Executive Officer, Executive Director
Age: 50
Alan Hippe Member of the Corporate Executive Committee, Chief Financial Officer, Information Technology Officer
Age: 50
Stephan Feldhaus Member of the Enlarged Corporate Executive Committee, Head Group Communications
Age: 55
Sophie Kornowski-Bonnet Member of the Enlarged Corporate Executive Committee, Head Roche Partnering
Age: 53
Osamu Nagayama Member of the Enlarged Corporate Executive Committee, Chairman and Chief Executive Officer Chugai
Age: 69
John C. Reed M.D., Ph.D. Member of the Enlarged Corporate Executive Committee, Head of Roche Pharma Research & Early Development
Age: 59
Michael David Varney Member of the Enlarged Corporate Executive Committee, Head Genetech Research and Early Development
Age: 59
Cristina A. Wilbur Member of the Executive Committee, Head Group Human Resources
Age: 50
Urs Jaisli Chief Compliance Officer
Age: 61
Gottlieb A. Keller Member of the Group Executive Committee, General Counsel, Secretary to the Board of Directors
Age: 63